{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:10:39Z","timestamp":1774260639986,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ruhr-University Bochum","award":["F823R-14"],"award-info":[{"award-number":["F823R-14"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.expneurol.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T23:21:33Z","timestamp":1515194493000},"page":"112-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington's disease"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-3943","authenticated-orcid":false,"given":"Oluwaseun","family":"Fatoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Kloster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Reick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Saft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg T.","family":"Epplen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Arning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisa","family":"Ellrichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2018.01.001_bb0005","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1523\/JNEUROSCI.1008-05.2005","article-title":"Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus","volume":"25","author":"Acuna-Goycolea","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0010","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1634\/stemcells.2008-0056","article-title":"Neuropeptide Y promotes neurogenesis in murine subventricular zone","volume":"26","author":"Agasse","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2018.01.001_bb0025","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jnnp.72.6.726","article-title":"Autonomic nervous system function in Huntington's disease","volume":"72","author":"Andrich","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","article-title":"Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity","volume":"15","author":"Apostol","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","article-title":"CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice","volume":"39","author":"Apostol","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"issue":"13","key":"10.1016\/j.expneurol.2018.01.001_bb0040","doi-asserted-by":"crossref","first-page":"E1642","DOI":"10.1073\/pnas.1416609112","article-title":"NPY stimulates autophagy in hypothalamic neurons","volume":"112","author":"Aveleira","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0045","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-\u03baB in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0055","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0060","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1073\/pnas.1004744108","article-title":"TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons","volume":"108","author":"Baydyuk","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2015.07.016","article-title":"Intranasal administration of glial-derived neurotrophicfactor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats","volume":"303","author":"Bender","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0070","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/mol.109.058677","article-title":"Selective and brain penetrant neuropeptide Y Y2 receptor antagonists discovered by whole-cell high-throughput screening","volume":"77","author":"Brothers","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.expneurol.2018.01.001_bb0080","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1096\/fj.13-243485","article-title":"Neuropeptide Y induces potent migration of human immature dendritic cells and promotes a Th2 polarization","volume":"28","author":"Buttari","year":"2014","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.expneurol.2018.01.001_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0893-133X(00)00231-1","article-title":"Neuropeptide Y Y1 and Y2 receptor mRNA expression in the prefrontal cortex of psychiatric subjects: relationship of Y2 subtype to suicidal behavior","volume":"25","author":"Caberlotto","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0090","first-page":"13","article-title":"BDNF attenuates IL-1\u03b2-induced F-actin remodeling by inhibiting NF-\u03baB signaling in hippocampal neurons","volume":"35","author":"Cai","year":"2014","journal-title":"Neuroendocrinol. Lett."},{"issue":"8","key":"10.1016\/j.expneurol.2018.01.001_bb0095","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/JMN:28:3:239","article-title":"Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice","volume":"28","author":"Carvajal","year":"2006","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2018.01.001_bb0105","first-page":"H1737","article-title":"Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors","volume":"273","author":"Chen","year":"1997","journal-title":"Am. J. Phys."},{"issue":"5","key":"10.1016\/j.expneurol.2018.01.001_bb0110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15252\/emmm.201606666","article-title":"An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice","volume":"9","author":"Cheng","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2018.01.001_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer's disease and amnestic mild cognitive impairment","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-013-1567-0","article-title":"NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection","volume":"376","author":"Croce","year":"2013","journal-title":"Mol. Cell Biochem."},{"issue":"3","key":"10.1016\/j.expneurol.2018.01.001_bb0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nbd.2009.02.017","article-title":"Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice","volume":"34","author":"Decressac","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2018.01.001_bb0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2010.07.022","article-title":"Neuropeptide Y modifies the disease course in the R6\/2 transgenic model of Huntington's disease","volume":"226","author":"Decressac","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0135","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.expneurol.2018.01.001_bb0140","doi-asserted-by":"crossref","first-page":"11076","DOI":"10.1128\/JVI.01022-10","article-title":"Neuropeptide Y has a protective role during murine retrovirus-induced neurological disease","volume":"84","author":"Du","year":"2010","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.expneurol.2018.01.001_bb0145","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1093\/hmg\/ddv271","article-title":"Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease","volume":"24","author":"Duarte-Neves","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.expneurol.2018.01.001_bb0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/60500448","article-title":"Characterization of neuropeptide Y receptor subtypes by synthetic NPY analogues and by anti-receptor antibodies","volume":"6","author":"Eckward","year":"2001","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.expneurol.2018.01.001_bb0155","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/s41598-017-04990-1","article-title":"Laquinimod treatment in the R6\/2 mouse model of Huntington's disease","volume":"7","author":"Ellrichmann","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphological and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"53","key":"10.1016\/j.expneurol.2018.01.001_bb0170","doi-asserted-by":"crossref","first-page":"41921","DOI":"10.1074\/jbc.M110.164020","article-title":"Neuropeptide Y modulation of interleukin-1\u03b2 (IL-1\u03b2)-induced nitric oxide production in microglia","volume":"285","author":"Ferreira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1471-4159.2011.07541.x","article-title":"Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility","volume":"120","author":"Ferreira","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1755-5949.2012.00314.x","article-title":"NPY intraperitoneal injections produce antidepressant-like effects and downregulate BDNF in the rat hypothalamus","volume":"18","author":"Gelfo","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0195","doi-asserted-by":"crossref","first-page":"21537","DOI":"10.1074\/jbc.M109.084202","article-title":"Impaired TrkB-mediated ERK1\/2 activation in huntington disease knock-in striatal cells involves reduced p52\/p46 Shc expression","volume":"285","author":"Gines","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005292","article-title":"Short-term striatal gene expression responses to brain-derived neurotrophic factor are dependent on MEK and ERK activation","volume":"4","author":"Gokce","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0205","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/mol.106.030718","article-title":"Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate","volume":"71","author":"Gomez-Lazaro","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0210","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/jnc.12052","article-title":"Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment","volume":"123","author":"Gon\u00e7alves","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0215","series-title":"Huntington's Disease","author":"Harper","year":"1991"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00194305","article-title":"The epidemiology of Huntington's disease","volume":"89","author":"Harper","year":"1992","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.expneurol.2018.01.001_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(02)00888-1","article-title":"Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease","volume":"331","author":"Hayes","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0230","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-kB-dependent inflammation in Huntington's disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0235","first-page":"407","article-title":"Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes","volume":"17","author":"Ingenhoven","year":"1997","journal-title":"J. Rec. Signal. Transdiscipl. Res."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0240","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1523\/JNEUROSCI.19-13-05409.1999","article-title":"Expression of the striatal DARPP-32\/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro","volume":"19","author":"Ivkovic","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0245","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2018.01.001_bb0250","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1471-4159.1999.0730641.x","article-title":"Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices","volume":"73","author":"King","year":"1999","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.expneurol.2018.01.001_bb0255","doi-asserted-by":"crossref","first-page":"242","DOI":"10.17305\/bjbms.2013.2332","article-title":"Effects of single-dose neuropeptide Y on levels of hippocampal BDNF, MDA, GSH, and NO in a rat model of pentylenetetrazole-induced epileptic seizure","volume":"13","author":"Kir","year":"2013","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00109-013-1092-3","article-title":"Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R","volume":"92","author":"Kloster","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(01)00463-8","article-title":"Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization","volume":"111","author":"Kopp","year":"2002","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.expneurol.2018.01.001_bb0270","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1210\/en.2014-1192","article-title":"Early intervention with intranasal NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats","volume":"155","author":"Laukova","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2007.11.058","article-title":"Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease","volume":"1194","author":"Lee","year":"2008","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.expneurol.2018.01.001_bb0280","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"issue":"9","key":"10.1016\/j.expneurol.2018.01.001_bb0285","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4103\/1673-5374.133140","article-title":"Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function","volume":"9","author":"Li","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(01)01982-6","article-title":"Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion","volume":"308","author":"Liu","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0295","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","article-title":"IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice","volume":"49","author":"Lopes","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-2952(98)00059-8","article-title":"Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades","volume":"56","author":"Lopez-Ilasaca","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0305","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer's disease","volume":"1153","author":"Maccioni","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2018.01.001_bb0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0315","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0166-4328(02)00201-2","article-title":"Changes in sleep-waking cycle after striatal excitotoxic lesions","volume":"136","author":"Mena-Segovia","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0320","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/npjparkd.2016.2","article-title":"Central nervous system uptake of intranasal glutathione in Parkinson's disease","volume":"2","author":"Mischley","year":"2016","journal-title":"NPJ Parkinson's dis."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fncel.2016.00037","article-title":"Impaired TrkB signaling underlies reduced BDNF-mediated trophic support of striatal neurons in the R6\/2 mouse model of Huntington's disease","volume":"10","author":"Nguyen","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2016.01.020","article-title":"Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats","volume":"318","author":"Pang","year":"2016","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.expneurol.2018.01.001_bb0340","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1432-1327.2001.01966.x","article-title":"Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor","volume":"268","author":"Parker","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0345","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.peptides.2006.07.032","article-title":"Self-regulation of agonist activity at the Y receptors","volume":"28","author":"Parker","year":"2007","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.expneurol.2018.01.001_bb0350","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpsychores.2004.02.001","article-title":"Sleep and quantitative EEG in neurodegenerative disorders","volume":"56","author":"Petit","year":"2004","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0355","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0360","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(99)02119-8","article-title":"Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition","volume":"848","author":"Redrobe","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0370","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2004.10.084","article-title":"Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence","volume":"375","author":"Rimondini","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.expneurol.2018.01.001_bb0375","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1167\/iovs.12-10776","article-title":"Neuropeptide Y receptors Y1 and Y2 are present in neurons and glial cells in rat retinal cells in culture","volume":"54","author":"Santos-Carvalho","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0380","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.expneurol.2018.01.001_bb0385","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/mol.51.4.597","article-title":"Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus","volume":"51","author":"Sheriff","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.expneurol.2018.01.001_bb0390","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1096\/fj.02-0885fje","article-title":"Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures","volume":"17","author":"Silva","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0395","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.peptides.2006.09.029","article-title":"Spinal mechanisms of NPY analgesia","volume":"28","author":"Smith","year":"2007","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.expneurol.2018.01.001_bb0400","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1074\/jbc.M115.678185","article-title":"Systemic central system (CNS)-targeted delivery of neuropeptide (NPY) reduces neurodegeneration and increases neural precursor cell proliferation in a mouse model of Alzeimer disease","volume":"291","author":"Spencer","year":"2016","journal-title":"J. Bio. Chem."},{"issue":"4","key":"10.1016\/j.expneurol.2018.01.001_bb0405","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0410","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1073\/pnas.0712303105","article-title":"Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain","volume":"105","author":"Stanic","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0415","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1098-1136(200003)30:1<82::AID-GLIA9>3.0.CO;2-8","article-title":"Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y-Y1 receptors","volume":"30","author":"St-Pierre","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0420","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1471-4159.2001.00651.x","article-title":"Role of phosphatidylinositide 3-kinase in brain-derived neurotrophic factor-induced DARPP-32 expression in medium size spiny neurons in vitro","volume":"79","author":"Stroppolo","year":"2001","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.expneurol.2018.01.001_bb0425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0430","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0435","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2018.01.001_bb0440","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","article-title":"MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition","volume":"33","author":"Taylor","year":"2013","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2018.01.001_bb0445","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0450","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1471-4159.2010.07154.x","article-title":"NPY promotes chemokines and neurogenesis in the rat subventricular zone","volume":"116","author":"Thiriet","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0455","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0460","doi-asserted-by":"crossref","first-page":"37445","DOI":"10.1074\/jbc.M110.125542","article-title":"Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway","volume":"285","author":"Varma","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0465","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1460-9568.1995.tb01057.x","article-title":"The neurotrophins BDNF, NT-3 and NT-4\/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro","volume":"7","author":"Ventimiglia","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0470","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.brainresbull.2006.02.020","article-title":"Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice","volume":"69","author":"Vig","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0475","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jnc.13624","article-title":"Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's disease: increased NPY levels and differential degradation of the NPY1\u201330 fragment","volume":"137","author":"Wagner","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0480","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/psc.1357","article-title":"Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development","volume":"17","author":"Walther","year":"2011","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0485","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.20051971","article-title":"A fundamental bimodal role for neuropeptide Y1 receptor in the immune system","volume":"202","author":"Wheway","year":"2005","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.expneurol.2018.01.001_bb0490","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington's disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0495","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/brain\/awq219","article-title":"Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures","volume":"133","author":"Woldbye","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2018.01.001_bb0500","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/157488906778773689","article-title":"Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide","volume":"1","author":"Xapelli","year":"2006","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0505","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"issue":"20","key":"10.1016\/j.expneurol.2018.01.001_bb0510","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters -amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.01.001_bb0515","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T14:01:18Z","timestamp":1575381678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488618300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":102,"alternative-id":["S0014488618300013"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.01.001","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}